This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gatenby, R. A. Articles by Gawlinski, E. T. Search for Related Content PubMed PubMed Citation Articles by Gatenby, R. A. Articles by Gawlinski, E. T.

The Glycolytic Phenotype in Carcinogenesis and Tumor Invasion

Insights through Mathematical Models

Departments of Radiology and Applied Mathematics, The University of Arizona, Tucson, Arizona 85724-5067 [R. A. G.], and Department of Physics, Temple University, Philadelphia, Pennsylvania 19122 [E. T. G.]

ABSTRACT

Malignant cells characteristically exhibit altered metabolic patterns when compared with normal mammalian cells with increased reliance on anaerobic metabolism of glucose to lactic acid even in the presence of abundant oxygen. The inefficiency of the anaerobic pathway is compensated by increased glucose flux, a phenomenon first noted by Otto Warburg 80 years ago and currently exploited for 2-fluoro-2-deoxy-D-glucose-positron emission tomography imaging in clinical radiology. The latter has demonstrated the glycolytic phenotype is a near-universal phenomenon in human cancers. The potential role of the glycolytic phenotype in facilitating tumor invasion has been investigated through mathematical models of the tumor-host interface. Modified cellular automaton and diffusion reaction models demonstrate protons will diffuse from the tumor into peritumoral normal tissue subjecting nontransformed cells adjacent to the tumor edge to an extracellular pH significantly lower than normal. This leads to normal cell death via p53-dependent apoptosis pathways, as well as degradation of the interstitial matrix, loss of intercellular gap junctions, enhanced angiogenesis, and inhibition of the host immune response to tumor antigens. Transformed cells maintain their proliferative capacity in acidic extracellular pH because of mutations in p53 or some other component in the apoptosis pathways. This allows tumor cells to remain proliferative and migrate into the peritumoral normal tissue producing the invasive phenotype. Mathematical models of invasive cancer based on tumor-induced acidification are consistent with extant data on tumor microenvironment and results from clinical positron emission tomography imaging, including the observed correlation between tumor invasiveness and glucose utilization. Novel treatment approaches focused on perturbation of the tumor microenvironment are predicted from the mathematical models and are supported by recent clinical data demonstrating the benefits of azotemia and metabolic acidosis in survival of patients with metastatic renal cancer. The evolutionary basis for adoption of the glycolytic phenotype during carcinogenesis remains unclear because it appears to confer significant competitive disadvantages on the tumor cells due to of inefficient energy production and expenditure of resources to remove the acid byproducts. We propose that the glycolytic phenotype represents a successful adaptation to environmental selection parameters because it confers the ability to invade. That is, the glycolytic phenotype allows the cell to move from the microenvironment of a premalignant lesion to adjacent normal tissue. There it competes with normal cells that are less fit than the populations within the tumor in a microenvironment of relative substrate abundance. The consequent unrestrained proliferation allows the glycolytic phenotype to emerge simultaneous with the transition from a premalignant lesion to an invasive cancer.

This article has been cited by other articles:

				D. A. Tennant, R. V. Duran, H. Boulahbel, and E. Gottlieb Metabolic transformation in cancer Carcinogenesis, August 1, 2009; 30(8): 1269 - 1280. [Abstract] [Full Text] [PDF]

				P. Vizan, S. Sanchez-Tena, G. Alcarraz-Vizan, M. Soler, R. Messeguer, M.D. Pujol, W.-N. P. Lee, and M. Cascante Characterization of the metabolic changes underlying growth factor angiogenic activation: identification of new potential therapeutic targets Carcinogenesis, June 1, 2009; 30(6): 946 - 952. [Abstract] [Full Text] [PDF]

				I. Samudio, M. Fiegl, T. McQueen, K. Clise-Dwyer, and M. Andreeff The Warburg Effect in Leukemia-Stroma Cocultures Is Mediated by Mitochondrial Uncoupling Associated with Uncoupling Protein 2 Activation Cancer Res., July 1, 2008; 68(13): 5198 - 5205. [Abstract] [Full Text] [PDF]

				A. De Milito, E. Iessi, M. Logozzi, F. Lozupone, M. Spada, M. L. Marino, C. Federici, M. Perdicchio, P. Matarrese, L. Lugini, et al. Proton Pump Inhibitors Induce Apoptosis of Human B-Cell Tumors through a Caspase-Independent Mechanism Involving Reactive Oxygen Species Cancer Res., June 1, 2007; 67(11): 5408 - 5417. [Abstract] [Full Text] [PDF]

				D. Piwnica, I. Fernandez, N. Binart, P. Touraine, P. A. Kelly, and V. Goffin A New Mechanism for Prolactin Processing into 16K PRL by Secreted Cathepsin D Mol. Endocrinol., December 1, 2006; 20(12): 3263 - 3278. [Abstract] [Full Text] [PDF]

				A. Tomiyama, S. Serizawa, K. Tachibana, K. Sakurada, H. Samejima, Y. Kuchino, and C. Kitanaka Critical role for mitochondrial oxidative phosphorylation in the activation of tumor suppressors bax and bak. J Natl Cancer Inst, October 18, 2006; 98(20): 1462 - 1473. [Abstract] [Full Text] [PDF]

				R. A. Gatenby, E. T. Gawlinski, A. F. Gmitro, B. Kaylor, and R. J. Gillies Acid-mediated tumor invasion: a multidisciplinary study. Cancer Res., May 15, 2006; 66(10): 5216 - 5223. [Abstract] [Full Text] [PDF]

				S. D. Seidel, W. T. Stott, H. L. Kan, B. R. Sparrow, and B. B. Gollapudi Gene Expression Dose-Response of Liver with a Genotoxic and Nongenotoxic Carcinogen International Journal of Toxicology, January 1, 2006; 25(1): 57 - 64. [Abstract] [Full Text] [PDF]

				X. Lu, W. Qin, J. Li, N. Tan, D. Pan, H. Zhang, L. Xie, G. Yao, H. Shu, M. Yao, et al. The Growth and Metastasis of Human Hepatocellular Carcinoma Xenografts Are Inhibited by Small Interfering RNA Targeting to the Subunit ATP6L of Proton Pump Cancer Res., August 1, 2005; 65(15): 6843 - 6849. [Abstract] [Full Text] [PDF]

				G. Schwerdt, R. Freudinger, C. Schuster, F. Weber, O. Thews, and M. Gekle Cisplatin-Induced Apoptosis Is Enhanced by Hypoxia and by Inhibition of Mitochondria in Renal Collecting Duct Cells Toxicol. Sci., May 1, 2005; 85(1): 735 - 742. [Abstract] [Full Text] [PDF]

				F. Turturro, E. Friday, R. Fowler, D. Surie, and T. Welbourne Troglitazone Acts on Cellular pH and DNA Synthesis through a Peroxisome Proliferator-Activated Receptor {gamma}-Independent Mechanism in Breast Cancer-Derived Cell Lines Clin. Cancer Res., October 15, 2004; 10(20): 7022 - 7030. [Abstract] [Full Text] [PDF]

				C. C. Maley, B. J. Reid, and S. Forrest Cancer Prevention Strategies That Address the Evolutionary Dynamics of Neoplastic Cells: Simulating Benign Cell Boosters and Selection for Chemosensitivity Cancer Epidemiol. Biomarkers Prev., August 1, 2004; 13(8): 1375 - 1384. [Abstract] [Full Text] [PDF]